Local ablative therapy Clinical Trials
2 recruitingRadiation
Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 2
Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer
Lung Cancer (NSCLC)
Chinese University of Hong Kong64 enrolled1 locationNCT07379476
Recruiting
LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Universitaire Ziekenhuizen KU Leuven39 enrolled1 locationNCT04216121